Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 17, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 19, 2026
DirectorOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000874716-26-000032
Filed / recorded
Feb 19, 2026, 11:00 PM UTC
Added to OQRO
Oct 2, 2026, 12:28 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
IDEXX LABORATORIES INC /DE
Issuer CIK
874716
Ticker
IDXX
Reporting person
Sophie V. Vandebroek
Relationship
Director
Security
Non-Qualified Stock Option (right-to-buy)
Table
Derivative (Table II)
Transaction date
Feb 17, 2026
Transaction code
M
Shares / units
945
Acquired / disposed
Disposed (D)
Shares owned after
0
Ownership form
Direct
Amendment
No
Footnotes from the filing
Not applicable
Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2023 annual meeting of stockholders, whichever event was earlier.